Collateral Effect of Covid-19 on Stroke Evaluation in the United States
Item
Click for External Resource*
Click to read full article*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Item Type
PublicationTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Title
Collateral Effect of Covid-19 on Stroke Evaluation in the United States
Subject
Description
The effect of the Covid-19 pandemic on medical care for conditions other than Covid-19 has been difficult to quantify. Any decrease in care for patients with acute conditions such as ischemic stroke may be consequential because timely treatment may decrease the incidence of disability.
Date
2020-05-08
Type
Citation
Kansagra, Akash P., Manu S. Goyal, Scott Hamilton, and Gregory W. Albers. 2020. "Collateral Effect of Covid-19 on Stroke Evaluation in the United States." New England Journal of Medicine.
Accessibility
Free online on NEJM
Was this resource helpful?